Pericyte NF-κB activation enhances endothelial cell proliferation and proangiogenic cytokine secretion in vitro

Physiological Reports

Volumn 3, Issue 4, 2015, Pages

  Labarbera, Katherine E ^a   Hyldahl, Robert D ^b   O’Fallon, Kevin S ^a   Clarkson, Priscilla M ^a   Witkowski, Sarah ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b BRIGHAM YOUNG UNIVERSITY   (United States)

Author keywords

Cytokine signaling; Microvasculature; NF B; Pericyte

Indexed keywords

ALPHA2 INTERFERON; CD146 ANTIGEN; CHEMOKINE RECEPTOR CCR2; EOTAXIN; FRACTALKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; SYNAPTOTAGMIN I;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE ACTIVATION; GENETIC MANIPULATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LUCIFERASE ASSAY; MUSCLE INJURY; PERICYTE; SIGNAL TRANSDUCTION;

EID: 85003571538     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.14814/phy2.12309     Document Type: Article

References (45)

1. Barcelos, L. S., A. M. Coelho, R. C. Russo, R. Guabiraba, A. L. Souza, G. Jr Bruno-Lima, et al. 2009. Role of the chemokines CCL3/MIP-1 alpha and CCL5/RANTES in sponge-induced inflammatory angiogenesis in mice. Microvasc. Res. 78:148–154.
2. Bauerle, K., R. Schweppe, G. Lund, G. Kotnis, G. Deep, R. Agarwal, et al. 2014. Nuclear Factor kappa B-dependent regulation of angiogenesis, and metastasis in an in vivo model of thyroid cancer is associated with secreted interleukin-8. J. Clin. Endocrinol. Metab. 99:E1436–E1444.
3. Boppart, M. D., M. De Lisio, K. Zou, and H. D. Huntsman. 2013. Defining a role for non-satellite stem cells in the regulation of muscle repair following exercise. Front. Physiol. 4:310.
4. Bryan, B. A., and P. A. D’Amore. 2008. Pericyte isolation and use in endothelial/pericyte coculture models. Methods Enzymol. 443:315–331.
5. Cai, D., J. D. Frantz, N. E. Jr Tawa, P. A. Melendez, B. C. Oh, H. G. Lidov, et al. 2004. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 119:285–298.
6. Catoire, M., M. Mensink, E. Kalkhoven, P. Schrauwen, and S. Kersten. 2014. Identification of human exercise-induced myokines using secretome analysis. Physiol. Genomics 46:256–267.
7. Chen, Y. W., M. J. Hubal, E. P. Hoffman, P. D. Thompson, and P. M. Clarkson. 2003. Molecular responses of human muscle to eccentric exercise. J. Appl. Physiol. (Bethesda, MD: 1985) 95:2485–2494.
8. Chen, C. W., M. Okada, J. D. Proto, X. Gao, N. Sekiya, S. A. Beckman, et al. 2013. Human pericytes for ischemic heart repair. Stem Cells 31:305–316.
9. Covas, D. T., R. A. Panepucci, A. M. Fontes, W. A. Jr Silva, M. D. Orellana, M. C. Freitas, et al. 2008. Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146 + perivascular cells and fibroblasts. Exp. Hematol. 36:642–654.
10. Crisan, M., S. Yap, L. Casteilla, C. W. Chen, M. Corselli, T. S. Park, et al. 2008. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3:301–313.
11. Dellavalle, A., G. Maroli, D. Covarello, E. Azzoni, A. Innocenzi, L. Perani, et al. 2011. Pericytes resident in postnatal skeletal muscle differentiate into muscle fibres and generate satellite cells. Nat. Commun. 2:499.
12. Diaz-Flores, L., R. Gutierrez, A. Lopez-Alonso, R. Gonzalez, and H. Varela. 1992. Pericytes as a supplementary source of osteoblasts in periosteal osteogenesis. Clin. Orthop. Relat. Res. 275:280–286.
13. Groen, B. B., H. M. Hamer, T. Snijders, J. van Kranenburg, D. Frijns, H. Vink, et al. 2014. Skeletal muscle capillary density and microvascular function are compromised with aging and type 2 diabetes. J. Appl. Physiol. (Bethesda, MD: 1985) 116:998–1005.
14. Guttridge, D. C., C. Albanese, J. Y. Reuther, R. G. Pestell, and A. S. Jr Baldwin. 1999. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell. Biol. 19:5785–5799.
15. Guttridge, D. C., M. W. Mayo, L. V. Madrid, C. Y. Wang, and A. S. Jr Baldwin. 2000. NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science (New York, NY) 289:2363–2366.
16. Hirschi, K. K., and P. A. D’Amore. 1996. Pericytes in the microvasculature. Cardiovasc. Res. 32:687–698.
17. Huntsman, H. D., N. Zachwieja, K. Zou, P. Ripchik, M. C. Valero, M. De Lisio, et al. 2013. Mesenchymal stem cells contribute to vascular growth in skeletal muscle in response to eccentric exercise. Am. J. Physiol. Heart Circ. Physiol. 304:H72–H81.
18. Hyldahl, R. D., L. Xin, M. J. Hubal, S. Moeckel-Cole, S. Chipkin, and P. M. Clarkson. 2011. Activation of nuclear factor-kappaB following muscle eccentric contractions in humans is localized primarily to skeletal muscle-residing pericytes. FASEB J. 25:2956–2966.
19. Hyldahl, R. D., L. M. Schwartz, and P. M. Clarkson. 2013. NF-κB activity functions in primary pericytes in a cell- and non-cell-autonomous manner to affect myotube formation. Muscle Nerve 47:522–531.
20. Kano, Y., K. Sampei, and H. Matsudo. 2004. Time course of capillary structure changes in rat skeletal muscle following strenuous eccentric exercise. Acta Physiol. Scand. 180:291–299.
21. Kano, Y., D. J. Padilla, B. J. Behnke, K. S. Hageman, T. I. Musch, and D. C. Poole. 2005. Effects of eccentric exercise on microcirculation and microvascular oxygen pressures in rat spinotrapezius muscle. J. Appl. Physiol. (Bethesda, MD: 1985) 99:1516–1522.
22. Khatami, M. 2011. Unresolved inflammation: ‘immune tsunami’ or erosion of integrity in immune-privileged and immune-responsive tissues and acute and chronic inflammatory diseases or cancer. Expert Opin. Biol. Ther. 11:1419–1432.
23. Koch, A. E., P. J. Polverini, S. L. Kunkel, L. A. Harlow, L. A. DiPietro, V. M. Elner, et al. 1992. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science (New York, NY) 258:1798–1801.
24. Lu, H., D. Huang, R. M. Ransohoff, and L. Zhou. 2011. Acute skeletal muscle injury: CCL2 expression by both monocytes and injured muscle is required for repair. FASEB J. 25:3344–3355.
25. Ma, J., Q. Wang, T. Fei, J. D. Han, and Y. G. Chen. 2007. MCP-1 mediates TGF-beta-induced angiogenesis by stimulating vascular smooth muscle cell migration. Blood 109:987–994.
26. Mehrad, B., M. P. Keane, and R. M. Strieter. 2007. Chemokines as mediators of angiogenesis. Thromb. Haemost. 97:755–762.
27. Mourkioti, F., P. Kratsios, T. Luedde, Y. H. Song, P. Delafontaine, R. Adami, et al. 2006. Targeted ablation of IKK2 improves skeletal muscle strength, maintains mass, and promotes regeneration. J. Clin. Invest. 116: 2945–2954.
28. Peterson, J. M., and F. X. Pizza. 2009. Cytokines derived from cultured skeletal muscle cells after mechanical strain promote neutrophil chemotaxis in vitro. J. Appl. Physiol. (Bethesda, MD: 1985) 106:130–137.
29. Peterson, J. M., N. Bakkar, and D. C. Guttridge. 2011. NF- kappaB signaling in skeletal muscle health and disease. Curr. Top. Dev. Biol. 96:85–119.
30. Richardson, R. L., G. J. Hausman, and D. R. Campion. 1982. Response of pericytes to thermal lesion in the inguinal fat pad of 10-day-old rats. Acta Anat. 114:41–57.
31. Romagnani, P., F. Annunziato, L. Lasagni, E. Lazzeri, C. Beltrame, M. Francalanci, et al. 2001. Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. J. Clin. Invest. 107:53–63.
32. Salcedo, R., M. L. Ponce, H. A. Young, K. Wasserman, J. M. Ward, H. K. Kleinman, et al. 2000. Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood 96:34–40.
33. Sassoli, C., A. Pini, F. Chellini, B. Mazzanti, S. Nistri, D. Nosi, et al. 2012. Bone marrow mesenchymal stromal cells stimulate skeletal myoblast proliferation through the paracrine release of VEGF. PLoS ONE 7:e37512.
34. Scheler, M., M. Irmler, S. Lehr, S. Hartwig, H. Staiger, H. Al-Hasani, et al. 2013. Cytokine response of primary human myotubes in an in vitro exercise model. Am. J. Physiol. Cell Physiol. 305:C877–C886.
35. Shao, R., and X. Guo. 2004. Human microvascular endothelial cells immortalized with human telomerase catalytic protein: a model for the study of in vitro angiogenesis. Biochem. Biophys. Res. Commun. 321:788–794.
36. Shepro, D., and N. M. Morel. 1993. Pericyte physiology. FASEB J. 7:1031–1038.
37. Shi, X., and D. J. Garry. 2006. Muscle stem cells in development, regeneration, and disease. Genes Dev. 20:1692–1708.
38. Silvestre, J. S., Z. Mallat, A. Tedgui, and B. I. Levy. 2008. Post- ischaemic neovascularization and inflammation. Cardiovasc. Res. 78:242–249.
39. Strieter, R. M., P. J. Polverini, D. A. Arenberg, and S. L. Kunkel. 1995. The role of CXC chemokines as regulators of angiogenesis. Shock (Augusta, GA) 4:155–160.
40. Suffee, N., B. Richard, H. Hlawaty, O. Oudar, N. Charnaux, and A. Sutton. 2011. Angiogenic properties of the chemokine RANTES/CCL5. Biochem. Soc. Trans. 39:1649–1653.
41. Tamaki, T., Y. Uchiyama, Y. Okada, T. Ishikawa, M. Sato, A. Akatsuka, et al. 2005. Functional recovery of damaged skeletal muscle through synchronized vasculogenesis, myogenesis, and neurogenesis by muscle-derived stem cells. Circulation 112:2857–2866.
42. Tilton, R. G., C. Kilo, and J. R. Williamson. 1979. Pericyte- endothelial relationships in cardiac and skeletal muscle capillaries. Microvasc. Res. 18:325–335.
43. Tsivitse, S. K., E. Mylona, J. M. Peterson, W. T. Gunning, and F. X. Pizza. 2005. Mechanical loading and injury induce human myotubes to release neutrophil chemoattractants. Am. J. Physiol. Cell Physiol. 288: C721–C729.
44. Westerweel, P. E., T. J. Rabelink, M. B. Rookmaaker, H. J. Grone, and M. C. Verhaar. 2008. RANTES is required for ischaemia-induced angiogenesis, which may hamper RANTES-targeted anti-atherosclerotic therapy. Thromb. Haemost. 99:794–795.
45. Yahiaoui, L., D. Gvozdic, G. Danialou, M. Mack, and B. J. Petrof. 2008. CC family chemokines directly regulate myoblast responses to skeletal muscle injury. J. Physiol. 586:3991–4004.